Nature’s Sunshine Products (NATR) Projected to Post Earnings on Thursday

Nature’s Sunshine Products (NASDAQ:NATR) is anticipated to announce its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Nature’s Sunshine Products to post earnings of $0.27 per share and revenue of $123.7040 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:00 PM ET.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its earnings results on Thursday, May 7th. The company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.10. The company had revenue of $122.89 million during the quarter, compared to the consensus estimate of $122.15 million. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.

Nature’s Sunshine Products Stock Performance

Shares of Nature’s Sunshine Products stock opened at $20.82 on Thursday. The firm has a 50-day moving average of $21.04 and a 200-day moving average of $23.67. The stock has a market cap of $366.02 million, a PE ratio of 18.93 and a beta of 0.87. Nature’s Sunshine Products has a 52-week low of $12.97 and a 52-week high of $28.14.

Insider Buying and Selling

In other news, EVP Nathan G. Brower sold 12,015 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $21.84, for a total transaction of $262,407.60. Following the completion of the sale, the executive vice president directly owned 43,438 shares in the company, valued at approximately $948,685.92. This represents a 21.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Daniel C. Norman sold 9,713 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $20.64, for a total value of $200,476.32. Following the sale, the executive vice president directly owned 47,276 shares in the company, valued at approximately $975,776.64. This trade represents a 17.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 35,696 shares of company stock valued at $742,407. 3.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Nature’s Sunshine Products

A number of large investors have recently bought and sold shares of the company. Price T Rowe Associates Inc. MD acquired a new position in shares of Nature’s Sunshine Products in the 4th quarter valued at approximately $232,000. Heron Bay Capital Management bought a new position in shares of Nature’s Sunshine Products in the fourth quarter worth about $275,000. NewEdge Advisors LLC boosted its position in Nature’s Sunshine Products by 2,113.6% in the third quarter. NewEdge Advisors LLC now owns 15,606 shares of the company’s stock valued at $242,000 after buying an additional 14,901 shares in the last quarter. Verition Fund Management LLC bought a new position in shares of Nature’s Sunshine Products in the 3rd quarter valued at $210,000. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Nature’s Sunshine Products during the 3rd quarter valued at $195,000. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently commented on NATR shares. Weiss Ratings lowered shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Canaccord Genuity Group set a $37.00 target price on shares of Nature’s Sunshine Products in a research report on Friday, May 8th. Finally, DA Davidson raised shares of Nature’s Sunshine Products to a “strong-buy” rating in a report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $35.00.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.